Cargando…

Antivirals/immunosuppressants: COVID-19 infection and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393035/ http://dx.doi.org/10.1007/s40278-020-81378-5

Ejemplares similares

Antibacterials/antivirals/immunosuppressants: COVID-19 infection, COVID-19 pneumonia and off-label use: 7 case reports
Publicado: (2022)

Immunosuppressants/azithromycin: Prolonged COVID-19 infection, off label use and lack of efficacy: case report
Publicado: (2021)

Corticosteroids/immunosuppressants/steroids: COVID-19 and lack of efficacy following off label use: 7 case reports
Publicado: (2022)

Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report
Publicado: (2020)

Immunosuppressants and antiviral: COVID-19 and lack of efficacy: case report
Publicado: (2022)

Antibacterials/antivirals: Erythema multiforme and off label use: 2 case reports
Publicado: (2020)

Amphotericin-B-liposomal/antibacterials/immunosuppressants: Various infections, nephrotoxicity and off-label use: 4 case reports
Publicado: (2022)

Multiple drugs: COVID-19 infection and off-label use: case report
Publicado: (2021)

Multiple durgs: COVID-19 infection and off label use: case report
Publicado: (2021)

Antibacterials/antivirals/dexamethasone: Aspergillus terreus infection, lack of efficacy and off label use: case report
Publicado: (2021)

Antibacterials/antivirals: Off-label use in COVID-19 pneumonia, and induction of resistance through mutation selection: case report
Publicado: (2021)

Multiple drugs: Off-label use, lack of efficacy and acquired immunosuppression syndrome: case report
Publicado: (2022)

Antivirals: Repolarisation and conduction disorder following off-label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine/immunosuppressants: Nosocomial coronavirus disease 2019 (COVID-19), leucopenia and prolonged persistence of COVID-19 following off-label use: case report
Publicado: (2020)

Bamlanivimab: Gene mutation in COVID-19 infection and off label use: case report
Publicado: (2022)

Hydroxychloroquine/immunosuppressants: Delayed viral clearance, drug interaction and off label use: 3 case reports
Publicado: (2021)

Ceftriaxone/doxycycline/immunosuppressants: Disseminated histoplasmosis following an off label use and lack of efficacy: case report
Publicado: (2022)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Dexamethasone/hydroxychloroquine: Reactivation of COVID-19 infection and off label use: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection, lack of efficacy and off-label use: case report
Publicado: (2021)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Antiviral/immunosuppressant: Various toxicities: case report
Publicado: (2020)

Antivirals/corticosteroids/withania somnifera: Rhino-orbital mucormycosis and off label use: 13 case reports
Publicado: (2022)

Multiple drugs: Infections and off label use: case report
Publicado: (2021)

Immunosuppressants/lopinavir/ritonavir interaction: Relapse or persisting shedding of COVID-2019 , increased level of tacrolimus and off-label use: case report
Publicado: (2021)

Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 and off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: COVID-19 and off-label use: 22 case reports
Publicado: (2021)

Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 infection, renal allograft infarction and off-label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 infection, drug induced psychosis and off-label use: case report
Publicado: (2021)

Multiple drugs: Recurrence of COVID-19 infection, off-label use and lack of efficacy: case report
Publicado: (2022)

Immunosuppressants: COVID-19 infection: case report
Publicado: (2022)

Antivirals/interferon-α-1b: Elevated aminotransferases and vomiting following off-label use: case report
Publicado: (2021)

Antivirals/immunosuppressants: Various toxicities: 3 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection, prolonged viral shedding and off-label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Drug ineffectiveness following off-label use in COVID-19 infection: case report
Publicado: (2022)

Favipiravir: Lack of efficacy secondary to off label use in COVID-19: Case report: case report
Publicado: (2021)

Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report
Publicado: (2020)

Dexamethasone: Nocardia infection followed by off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pslu6641fumosse257vncbgi6p